ribavirin has been researched along with Anemia, Cooley's in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.14) | 18.2507 |
| 2000's | 5 (35.71) | 29.6817 |
| 2010's | 8 (57.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akriviadis, E; Arvaniti, P; Bellou, A; Dalekos, GN; Goulis, I; Karatapanis, S; Kattamis, A; Koskinas, J; Kountouras, D; Kourakli, A; Maragkos, K; Papatheodoridis, GV; Petropoulou, F; Sinakos, E; Tampaki, M; Toli, B; Triantos, C; Tsiaoussis, G; Vassiliadis, T; Vlachaki, E; Zachou, K | 1 |
| Ahmad, W; Alam, SE; Asif, M; Hussain Jaffery, SS; Sajjad, SF | 1 |
| Gandhi, M; Jhaveri, A; Merchant, R; Nagral, A; Nagral, N; Parikh, NS; Sawant, S | 1 |
| Bronte, F; Calvaruso, V; D'Ambrosio, R; Di Marco, V; Forni, G; Lanza, AG; Poggiali, E; Saracco, G | 1 |
| Amiot, X; Ancel, D; Chaslin-Ferbus, D; Garioud, A; Girot, R; Grange, JD; Hagege, I; Pol, S | 1 |
| Alavian, SM; Tabatabaei, SV | 1 |
| Inati, A; Musallam, KM; Sharara, AI; Taher, AT | 1 |
| Kaur, A; Kaushal, S; Midha, V; Mittal, R; Puri, S; Singla, D; Sobti, P; Sood, A; Sood, N | 1 |
| Kalpaka, A; Klonizakis, P; Paschos, P; Pasvanti, C; Perifanis, V; Sinakos, E; Vlachaki, E | 1 |
| Kermack, D; Senosier, M; Sherker, AH | 1 |
| Aoun, E; Ghorra, S; Inati, A; Koussa, S; Sharara, AI; Taha, M; Taher, A | 1 |
| Hamidah, A; Jamal, R; Thambidorai, CR | 1 |
| Bouloux, P; Hoffbrand, AV; Jensen, C; Telfer, P; Wonke, B | 1 |
| Chan, PK; Ha, SY; Li, CK; Ling, SC | 1 |
1 review(s) available for ribavirin and Anemia, Cooley's
| Article | Year |
|---|---|
New approaches to the management of hepatitis and endocrine disorders in Cooley's anemia.
Topics: Antiviral Agents; beta-Thalassemia; Child; Endocrine System Diseases; Female; Growth; Hepatitis C; Humans; Incidence; Interferon-alpha; Liver Cirrhosis; Osteoporosis; Pregnancy; Pregnancy Complications; Ribavirin; Sex Characteristics | 1998 |
5 trial(s) available for ribavirin and Anemia, Cooley's
| Article | Year |
|---|---|
Efficacy and safety of pegylated IFN alfa 2b alone or in combination with ribavirin in thalassemia major with chronic hepatitis C.
Topics: Adolescent; Adult; Antiviral Agents; beta-Thalassemia; Child; Child, Preschool; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Prospective Studies; Recombinant Proteins; Ribavirin; Treatment Outcome; Young Adult | 2010 |
Safety and efficacy of combination therapy with pegylated interferon alpha-2a and ribavirin in treating patients with chronic hepatitis C and beta-thalassaemia major: a Greek single-center experience.
Topics: Adult; Antiviral Agents; beta-Thalassemia; Chelation Therapy; Drug Therapy, Combination; Female; Greece; Hepatitis C, Chronic; Homozygote; Humans; Interferon alpha-2; Interferon-alpha; Iron Chelating Agents; Iron Overload; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Transfusion Reaction; Treatment Outcome | 2011 |
Treatment of transfusion-dependent thalassemic patients infected with hepatitis C virus with interferon alpha-2b and ribavirin.
Topics: Adult; Antiviral Agents; beta-Thalassemia; Blood Transfusion; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Recombinant Proteins; Ribavirin | 2003 |
Efficacy and tolerability of peginterferon alpha-2a with or without ribavirin in thalassaemia major patients with chronic hepatitis C virus infection.
Topics: Adolescent; Adult; Antiviral Agents; beta-Thalassemia; Blood Transfusion; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Lebanon; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; RNA, Viral; Viral Load | 2005 |
Interferon and ribavirin as frontline treatment for chronic hepatitis C infection in thalassaemia major.
Topics: Adolescent; Adult; Antiviral Agents; beta-Thalassemia; Child; Drug Therapy, Combination; Female; Follow-Up Studies; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Recombinant Proteins; Ribavirin; Transfusion Reaction | 2002 |
8 other study(ies) available for ribavirin and Anemia, Cooley's
| Article | Year |
|---|---|
Treatment of chronic hepatitis C with direct-acting antivirals in patients with β-thalassaemia major and advanced liver disease.
Topics: Adult; Antiviral Agents; beta-Thalassemia; Carbamates; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Imidazoles; Liver Cirrhosis; Male; Middle Aged; Pyrrolidines; Ribavirin; Severity of Illness Index; Simeprevir; Sofosbuvir; Valine | 2017 |
Treatment of chronic Hepatitis C in Thalassemia major patients.
Topics: Adolescent; Adult; Anemia; Antiviral Agents; beta-Thalassemia; Child; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferons; Male; Pilot Projects; Ribavirin; RNA, Viral; Sustained Virologic Response; Young Adult | 2017 |
Treatment of Chronic Hepatitis C Infection with Direct Acting Antivirals in Adolescents with Thalassemia Major.
Topics: Adolescent; Antiviral Agents; Benzimidazoles; beta-Thalassemia; Carbamates; Child; Drug Therapy, Combination; Female; Fluorenes; Genotype; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Imidazoles; Liver Cirrhosis; Male; Prospective Studies; Pyrrolidines; Ribavirin; Sofosbuvir; Sustained Virologic Response; Treatment Outcome; Valine; Viral Load | 2019 |
Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?
Topics: Adult; Antiviral Agents; beta-Thalassemia; Drug Therapy, Combination; Female; Heart Diseases; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Interleukins; Italy; Liver Cirrhosis; Logistic Models; Male; Multivariate Analysis; Polymorphism, Single Nucleotide; Retrospective Studies; Ribavirin; Treatment Outcome; Viral Load | 2016 |
Treatment of chronic hepatitis C in sickle cell disease and thalassaemic patients with interferon and ribavirin.
Topics: Adolescent; Adult; Anemia, Hemolytic; Anemia, Sickle Cell; Antiviral Agents; beta-Thalassemia; Dose-Response Relationship, Drug; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferons; Male; Pilot Projects; Ribavirin; Treatment Outcome; Young Adult | 2009 |
Treatment outcome of chronic hepatitis C in sickle cell disease and thalassemic patients with interferon and ribavirin.
Topics: Anemia, Sickle Cell; Antiviral Agents; beta-Thalassemia; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferons; Ribavirin; Treatment Outcome | 2010 |
The role of liver iron in hepatitis C antiviral treatment.
Topics: Anemia, Sickle Cell; Antiviral Agents; beta-Thalassemia; Blood Transfusion; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Iron; Liver; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2010 |
Peginterferon alfa-2b and ribavirin in thalassaemia/chronic hepatitis C virus-co-infected non-responder to standard interferon-based.
Topics: Adult; Antiviral Agents; beta-Thalassemia; Comorbidity; Drug Therapy, Combination; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Interferons; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Failure | 2005 |